T1	Participants 86 196	intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients.
T2	Participants 377 425	patients with aggressive non-Hodgkin's lymphoma.
T3	Participants 760 812	intermediate- and high-grade non-Hodgkin's lymphoma.
T4	Participants 834 917	Patients were younger than 55 years and had at least one adverse prognostic factor.
T5	Participants 1158 1170	464 patients
